| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 04/13/1993 | US5202420 Pure genetically engineered peptides which inhibit growth of escherichia |
| 04/13/1993 | US5202419 Anticoagulative protein pp4-x |
| 04/13/1993 | US5202415 Having 29 first amino acids of B chain of human insulin linked to 21 amino acids of A chain by specified amino acids |
| 04/13/1993 | US5202257 Pure DNA which is capable of hybridizing with receptor polynucleotides under mild conditions |
| 04/13/1993 | US5202251 Produced by immunization with specific peptide; used to isolate and purify enzyme |
| 04/13/1993 | US5202247 Hybrid protein containing polypeptide fused to substrate binding region of amino acid sequence |
| 04/13/1993 | US5202241 Spectrum analysis of physiochemical and biological properties; useful in treatment of infection diseases involving microorganism susceptible to them; culture product |
| 04/13/1993 | US5202239 Expression of recombinant polypeptides with improved purification |
| 04/13/1993 | US5202238 Production of chimeric antibodies by homologous recombination |
| 04/13/1993 | US5202235 Enzymatic method for the synthesis and separation of peptides |
| 04/13/1993 | US5202117 Method of treating thrombi with g-csf |
| 04/13/1993 | CA1316133C Method of using bar1 for secreting foreign proteins |
| 04/13/1993 | CA1316132C Cdna and gene for human angiogenin (angiogenesis factor) and method of expression |
| 04/12/1993 | CA2080258A1 Process for the purification of streptolysin o, intact streptolysin o obtainable by this process and its use |
| 04/11/1993 | CA2080309A1 Mutations in ryanodine receptor causative of human malignant hyperthermia |
| 04/08/1993 | CA2079439A1 Non-a, non-b peptides |
| 04/07/1993 | EP0535967A2 Cyclohexapeptidyl bisamine compounds |
| 04/07/1993 | EP0535663A2 Novel antibodies useful for the detection of benign and malignant tumors |
| 04/07/1993 | EP0535576A1 New conjugates to introduce nucleic acid into higher eucaryotic cells |
| 04/07/1993 | EP0535347A2 Monoclonal antibodies to sulfonated polymers |
| 04/07/1993 | EP0535161A1 Expression vectors containing the hiv nef gene to enhance replication efficiency |
| 04/07/1993 | EP0535119A1 A novel vector to produce biologically important peptides |
| 04/07/1993 | EP0535092A1 Protease nexin-i variants |
| 04/07/1993 | EP0535088A1 Chimeric toxins with improved inter-domain geometry |
| 04/07/1993 | EP0535084A1 Improved ascites production of monoclonal antibodies using an immunosuppressive anti-cd4-related antibody |
| 04/07/1993 | EP0535060A1 Antifungal polypeptide, process for producing it. |
| 04/07/1993 | EP0535053A1 RECOMBINANT 47 AND 31kD COCOA PROTEINS AND PRECURSOR |
| 04/07/1993 | EP0535039A1 Novel bacteriocin from a strain of lactococcus lactis subsp. cremoris |
| 04/07/1993 | EP0535007A1 A MONOCLONAL ANTIBODY AGAINST THE GAG PROTEIN PRECURSOR p55 OF HUMAN IMMUNODEFICIENCY VIRUS. |
| 04/07/1993 | EP0534992A1 Process for producing peptides. |
| 04/07/1993 | EP0534988A1 Inhibitors of factor xii activation and applications thereof |
| 04/07/1993 | EP0534978A1 Interleukin-1 antagonist and uses thereof |
| 04/07/1993 | EP0491849A4 A method for the purification of transforming growth factor (tgf-) |
| 04/07/1993 | EP0233936B1 Synthetic polypeptides for detecting mycobacterial infections |
| 04/07/1993 | EP0215110B1 Production of human somatomedin c |
| 04/07/1993 | CN1070685A Multiple hepatitis B virus surface proteins which form particles |
| 04/06/1993 | US5200510 Utilizing a preferential binding peptide bound to an insoluble matrix; elution; collection |
| 04/06/1993 | US5200505 R106 compounds |
| 04/06/1993 | CA1315716C Monoclonal antibodies to the light chain region of human factor xii and methods of preparing and using the same |
| 04/06/1993 | CA1315715C Human cell line and triomas, antibodies, and transformants derived therefrom |
| 04/01/1993 | WO1993006489A1 Method to detect tumor necrosis factor (tnf) as bioactive form |
| 04/01/1993 | WO1993006233A1 Tumor immunotherapy utilizing a method of overcoming the resistance of a progressively growing tumor |
| 04/01/1993 | WO1993006232A1 HUMAN MONOCLONAL ANTIBODY AGAINST GLYCOPROTEIN IIb/IIIa |
| 04/01/1993 | WO1993006231A1 Anti-human milk fat globule humanised antibodies |
| 04/01/1993 | WO1993006228A1 A new form of liposaccharide binding protein (lbp) |
| 04/01/1993 | WO1993006219A1 Secondary-metabolite biosynthesis genes from actinomycetes, method of isolating them, and their use |
| 04/01/1993 | WO1993006217A1 EXPRESSION IN E. COLI OF ANTIBODY FRAGMENTS HAVING AT LEAST A CYSTEINE PRESENT AS A FREE THIOL, USE FOR THE PRODUCTION OF BIFUNCTIONAL F(ab')2 ANTIBODIES |
| 04/01/1993 | WO1993006213A1 Production of chimeric antibodies - a combinatorial approach |
| 04/01/1993 | WO1993006134A1 Factors for the cellular functional regulation and biological applications thereof |
| 04/01/1993 | WO1993006133A1 Immunoassay for identifying alcoholics and monitoring alcohol consumption |
| 04/01/1993 | WO1993006131A1 Porcine adipocyte antigens and their use in the immunological control of fat |
| 04/01/1993 | WO1993006126A1 Immunoreactive hepatitis c virus polypeptide compositions |
| 04/01/1993 | WO1993006123A1 Human cyclin e |
| 04/01/1993 | WO1993006117A1 Sf-25 antibodies, especially chimeric antibodies, with specificity for the human tumor sf-25 antigen, methods for their production, and uses thereof |
| 04/01/1993 | WO1993006116A1 Glial derived neurotrophic factor |
| 04/01/1993 | WO1993005813A1 Method of producing antibodies to a restricted population of t lymphocytes, antibodies and method of use |
| 04/01/1993 | WO1993003148A3 Tau/neurofilament protein kinases pk40 and pk36 |
| 04/01/1993 | WO1992022583A3 Tri- and tetra-valent monospecific antigen-binding proteins |
| 04/01/1993 | CA2120036A1 Method of producing antibodies to a restricted population of t lymphocytes, antibodies produced therefrom and methods of use thereof |
| 04/01/1993 | CA2119379A1 Secondary-metabolite biosynthesis genes from actinomycetes, method of isolating them and their use |
| 04/01/1993 | CA2119003A1 Factors for the cellular functional regulation and biological applications thereof |
| 04/01/1993 | CA2116033A1 Porcine adipocyte antigens and their use in the immunological control of fat |
| 03/31/1993 | EP0534878A1 Recombinant DNA molecules containing the coding part of a VBeta17 chain of the T cell antigen receptor and uses thereof |
| 03/31/1993 | EP0534764A1 Protein-dimeric polysaccharide conjugate vaccine |
| 03/31/1993 | EP0534742A1 Anti-human milk fat globule humanised antibodies |
| 03/31/1993 | EP0534705A2 Expression of low molecular weight recombinant polypeptides |
| 03/31/1993 | EP0534568A2 Human growth hormone analogues and their use |
| 03/31/1993 | EP0534383A2 Process for preparing human coagulation factor VIII protein complex |
| 03/31/1993 | EP0534102A1 Human cytomegalovirus specific peptides and use thereof |
| 03/31/1993 | EP0533942A1 Process for expressing polypeptide |
| 03/31/1993 | EP0533913A1 Novel endopeptidase |
| 03/31/1993 | EP0533862A1 Recombinant human factor viii derivatives |
| 03/31/1993 | EP0533849A1 SUCROSE PHOSPHATE SYNTHASE (SPS), ITS PROCESS FOR PREPARATION, ITS cDNA, AND UTILIZATION OF cDNA TO MODIFY THE EXPRESSION OF SPS IN THE PLANT CELLS |
| 03/31/1993 | EP0533846A1 The ciliary neurotrophic factor receptor |
| 03/31/1993 | EP0533841A1 Novel methods for producing antigen-specific, high-affinity human monoclonal antibodies |
| 03/31/1993 | EP0533830A1 Measuring non-dystrophin proteins and diagnosing muscular dystrophy |
| 03/31/1993 | EP0497894A4 Receptor infection assay |
| 03/31/1993 | EP0470976B1 Processes and compositions for the isolation of human relaxin |
| 03/31/1993 | EP0466854A4 T cell growth factor |
| 03/31/1993 | EP0281604B1 Single polypeptide chain binding molecules |
| 03/31/1993 | EP0253870B1 Method for producing factor viii:c-type proteins |
| 03/31/1993 | CN1070409A Prodrug activated by targeted catalytic proteins |
| 03/30/1993 | US5198541 Dna encoding bactericidal/permeability-increasing proteins |
| 03/30/1993 | US5198360 Microorganisms transformed with recombinant DNA vector |
| 03/30/1993 | US5198359 Recombinant protein receptor for il-2 |
| 03/30/1993 | US5198350 Viricides |
| 03/30/1993 | US5198345 Aspergillus, DNA construct for transforming host |
| 03/30/1993 | US5197973 Polypeptide |
| 03/30/1993 | CA1315480C Phosphopeptides |
| 03/30/1993 | CA1315231C Kibdelosporangium aridum sk&f-aad-609 |
| 03/30/1993 | CA1315225C Polypeptide useful for the allevation, treatment and diagnosis of auto-immune diseases, especially arthritic conditions, etc. |
| 03/30/1993 | CA1315221C Assay for aflatoxins |
| 03/30/1993 | CA1315219C Monoclonal antibodies against human carcinoembryonic antigen, processes for their production and their use |
| 03/27/1993 | CA2079197A1 Recombinant nda new molecules containing the codifying part of a vbeta 17 chain for the t-cells antigene receptor, preparat ion process, antibodies and drugs containing them |
| 03/25/1993 | CA2079027A1 Increased expression of low molecular weight recombinant polypeptides |
| 03/25/1993 | CA2078721A1 Process for preparing human coagulation factor viii protein complex |
| 03/25/1993 | CA2078359A1 Protein-dimeric polysaccharide conjugate vaccine |
| 03/24/1993 | EP0533492A2 A hepatitis B vaccine formulation incorporating a bile acid salt |
| 03/24/1993 | EP0533350A1 DNA encoding precursor interleukin 1B converting enzyme |
| 03/24/1993 | EP0533263A2 A multivalent hepatitis B virus vaccine |